In November 2015 the Spanish Agency for the Protection of Health in Sport (Agencia Española de Protección de la Salud en el Deporte, AEPSAD) has reported an anti-doping rule violation against the respondent E45 after his sample tested positive for the prohibited substance prednisone. The minor respondent mentioned the use of prednisone on the Doping Controle Form without a TUE.
After notification the representative of the minor respondent admitted the violation and submitted that the substances were used as prescribed medication for the respondent’s medical condition, sustained by medical files and without intention to enhance performance.
In addition the respondent’s application for a TUE was approved on 19 November 2015 and filed as evidence in his defence.
Considering the evidence and mitigating circumstances AEPSAD decides on 13 January to impose a warning on the respondent including forfeiture of any medals, points and prizes won in the competition.
